Friday, July 11, 2008

Welcome

If you have arrived at this blog, you are probably either interested in learning more about Dr. Samir Quawasmi, his new procedure for treating Keratoconus, or about the condition of Keratoconus. My name is Joseph Andrew Wilson and I have created this blog to share information with you about all three of these subjects.


Dr. Samir Quawasmi MD, DORCSI, DORCPI resides and practices in Amman, Jordan. He is held in high regard in his field and currently balances his professonal career by providing nonsurgical and surgical treatments to clients, providing professional consultation to other physicians around the world who seek his expert advice, and research and development of new surgical procedures that will improve vision for people worldwide.


Keratoconus is a degenerative non-inflammatory disorder of the eye in which the structural changes in the cornea cause it to thin and change to a more conical shape than its normal gradual curve. Keratoconus is a little-understood disease and its progression following diagnosis is unpredictable.




Dr. Quawasmi has developed the BADER PROCEDURE, an innovative approach to the treatment of Keratoconus. The Bader procedure (pronounced bay-dur and meaning 'full moon' in the Arabic language ) utilizes the human body's own ability of healing to correct this debilitating disease and requires minimal invasion of the eye buy the surgeon. With the Bader Procedure, contact lenses, which may cause 20% corneal endothelium loss over five years of use and other complications, are no longer necessary. Rings and grafts are no longer essential as a method of keratoconus treatment and corneal transplant, which has up to a 5 year window for rejection by the body.

Over 200 procedures have been performed by Dr. Quawasmi, without complication. Patient benefits include outpatient procedure, use of local anesthetic, timeliness of procedure, less financial expenditure for the patient when compared to other corrective procedures and corneal transplanting can be avoided as a treatment alternative.

No comments: